UCB (UCBJF) announced it will present pioneering TK2d research at the UMDF Mitochondrial Medicine 2025 Conference taking place June 18-21, 2025, in St. Louis, Missouri. UCB will present findings from disease course studies of TK2d in untreated patients, looking at disease progression and outcomes over time, as well as real-world insights into the burden and impact on caregivers, providing a comprehensive view of the experiences and challenges faced by those supporting individuals with TK2d.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UCBJF: